Hope for tardive dyskinesia: new drug trial targets stubborn symptoms
NCT ID NCT07105111
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tests whether valbenazine can reduce involuntary muscle movements in people with tardive dyskinesia who still have symptoms despite prior treatment. About 50 adults with schizophrenia, bipolar disorder, or major depression will take valbenazine for 24 weeks. The goal is to see if it improves movement control and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurocrine Clinical Site
RECRUITINGBryant, Arkansas, 72022, United States
-
Neurocrine Clinical Site
RECRUITINGChino, California, 91710, United States
-
Neurocrine Clinical Site
RECRUITINGFountain Valley, California, 92708, United States
-
Neurocrine Clinical Site
RECRUITINGFresno, California, 93720, United States
-
Neurocrine Clinical Site
RECRUITINGLong Beach, California, 90807, United States
-
Neurocrine Clinical Site
RECRUITINGOrange, California, 92866, United States
-
Neurocrine Clinical Site
RECRUITINGRedlands, California, 92373, United States
-
Neurocrine Clinical Site
RECRUITINGSan Diego, California, 92123, United States
-
Neurocrine Clinical Site
RECRUITINGBonita Springs, Florida, 34134, United States
-
Neurocrine Clinical Site
RECRUITINGHialeah, Florida, 33012, United States
-
Neurocrine Clinical Site
RECRUITINGMiami, Florida, 33144, United States
-
Neurocrine Clinical Site
RECRUITINGMiami, Florida, 33176, United States
-
Neurocrine Clinical Site
RECRUITINGOrange City, Florida, 32763, United States
-
Neurocrine Clinical Site
RECRUITINGPort Charlotte, Florida, 33980, United States
-
Neurocrine Clinical Site
RECRUITINGTampa, Florida, 33629, United States
-
Neurocrine Clinical Site
RECRUITINGAugusta, Georgia, 30912, United States
-
Neurocrine Clinical Site
RECRUITINGMarietta, Georgia, 30060, United States
-
Neurocrine Clinical Site
RECRUITINGNaperville, Illinois, 60563, United States
-
Neurocrine Clinical Site
RECRUITINGOmaha, Nebraska, 68124, United States
-
Neurocrine Clinical Site
RECRUITINGIndependence, Ohio, 44131, United States
-
Neurocrine Clinical Site
RECRUITINGRichmond, Virginia, 23226, United States
Conditions
Explore the condition pages connected to this study.